IN2012KN03036A - - Google Patents

Info

Publication number
IN2012KN03036A
IN2012KN03036A IN3036KON2012A IN2012KN03036A IN 2012KN03036 A IN2012KN03036 A IN 2012KN03036A IN 3036KON2012 A IN3036KON2012 A IN 3036KON2012A IN 2012KN03036 A IN2012KN03036 A IN 2012KN03036A
Authority
IN
India
Prior art keywords
ngf
aptamer
ugaaaraaacc
cgaamraaacu
satisfying
Prior art date
Application number
Other languages
English (en)
Inventor
Yoshikazu Nakamura
Ling Jin
Hisanao Hiramatsu
Original Assignee
Ribomic Inc
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribomic Inc, Shionogi & Co filed Critical Ribomic Inc
Publication of IN2012KN03036A publication Critical patent/IN2012KN03036A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3515—Lipophilic moiety, e.g. cholesterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
IN3036KON2012 2010-03-24 2011-03-24 IN2012KN03036A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010068546 2010-03-24
PCT/JP2011/057105 WO2011118682A1 (ja) 2010-03-24 2011-03-24 Ｎｇｆに対するアプタマー及びその使用

Publications (1)

Publication Number Publication Date
IN2012KN03036A true IN2012KN03036A (pl) 2015-04-10

Family

ID=44673231

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3036KON2012 IN2012KN03036A (pl) 2010-03-24 2011-03-24

Country Status (17)

Country Link
US (1) US9175292B2 (pl)
EP (1) EP2551346B1 (pl)
JP (1) JP5027956B2 (pl)
KR (1) KR101806429B1 (pl)
CN (1) CN102844436B (pl)
AU (1) AU2011230388B2 (pl)
BR (1) BR112012024232A8 (pl)
CA (1) CA2794199C (pl)
DK (1) DK2551346T3 (pl)
ES (1) ES2567270T3 (pl)
HR (1) HRP20160378T1 (pl)
HU (1) HUE028939T2 (pl)
IN (1) IN2012KN03036A (pl)
PL (1) PL2551346T3 (pl)
SI (1) SI2551346T1 (pl)
TW (1) TWI500425B (pl)
WO (1) WO2011118682A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ602618A (en) 2010-04-12 2013-12-20 Somalogic Inc Aptamers to beta-ngf and their use in treating beta-ngf mediated diseases and disorders
EP2762569B1 (en) * 2011-09-28 2018-06-13 RIBOMIC Inc. Ngf aptamer and application thereof
EP3124607A4 (en) * 2014-03-27 2017-11-22 Ribomic Inc. Aptamer inhibiting biological activity of autotaxin by binding with autotaxin, and use thereof
CN106018843A (zh) * 2015-11-29 2016-10-12 卢美珍 一种用于人脑疾病检测的试剂盒
CN108368509B (zh) * 2015-12-04 2022-03-22 全药工业株式会社 改善了血中滞留性的抗il－17适体
WO2019210194A1 (en) * 2018-04-26 2019-10-31 Vitrisa Therapeutics, Inc. Pegylated compositions for ocular use, and methods thereof
CN114540349B (zh) * 2020-11-27 2024-11-22 中国科学院分子细胞科学卓越创新中心 结合yb-1蛋白的核酸分子
CN115074367B (zh) * 2022-06-22 2024-12-13 复旦大学附属眼耳鼻喉科医院 一组与脑源性神经营养因子高亲和力结合的核酸适配体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE318832T1 (de) 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
ATE315101T1 (de) 1992-09-29 2006-02-15 Gilead Sciences Inc Nukleinsäureliganden und ihre herstellungsmethoden
EP0724647A4 (en) 1993-09-08 2003-09-17 Gilead Sciences Inc NUCLEIC ACIDS AS LIGANDS AND IMPROVED PRODUCTION METHODS
US20060057573A1 (en) 2002-02-15 2006-03-16 Somalogic, Inc Methods and reagents for detecting target binding by nucleic acid ligands
US20030054360A1 (en) 1999-01-19 2003-03-20 Larry Gold Method and apparatus for the automated generation of nucleic acid ligands
US7255860B2 (en) 2002-10-08 2007-08-14 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
WO2004032870A2 (en) 2002-10-08 2004-04-22 Rinat Neuroscience Corp. Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same
UA80447C2 (en) 2002-10-08 2007-09-25 Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
KR20050111598A (ko) 2003-02-19 2005-11-25 리나트 뉴로사이언스 코퍼레이션 신경 성장 인자 길항제 및 ｎｓａｉｄ를 투여함으로써통증을 치료하는 방법 및 그것을 함유하는 조성물
KR101637908B1 (ko) 2004-04-07 2016-07-11 리나트 뉴로사이언스 코프. 신경성장인자 길항제의 투여에 의한 골암 통증의 치료방법
ES2397715T3 (es) 2006-11-14 2013-03-08 Ribomic Inc Aptámero contra midkina y uso del mismo
WO2010008001A1 (ja) 2008-07-14 2010-01-21 国立大学法人 東京大学 Ｉｌ－１７に対するアプタマー及びその使用
RU2011116175A (ru) * 2008-09-24 2012-10-27 Рибомик Инк. (Jp) Аптамер к ngf и его применение

Also Published As

Publication number Publication date
EP2551346A4 (en) 2014-04-30
CN102844436A (zh) 2012-12-26
DK2551346T3 (en) 2016-04-11
CA2794199A1 (en) 2011-09-29
AU2011230388B2 (en) 2016-09-08
KR101806429B1 (ko) 2017-12-07
EP2551346B1 (en) 2016-01-27
PL2551346T3 (pl) 2016-07-29
TWI500425B (zh) 2015-09-21
SI2551346T1 (sl) 2016-05-31
ES2567270T3 (es) 2016-04-21
BR112012024232A8 (pt) 2018-02-06
US20130052176A1 (en) 2013-02-28
HRP20160378T1 (hr) 2016-05-20
KR20130028917A (ko) 2013-03-20
AU2011230388A2 (en) 2012-11-15
CA2794199C (en) 2017-11-14
CN102844436B (zh) 2015-11-25
AU2011230388A1 (en) 2012-11-01
HUE028939T2 (en) 2017-01-30
BR112012024232A2 (pt) 2016-11-29
US9175292B2 (en) 2015-11-03
JP5027956B2 (ja) 2012-09-19
JPWO2011118682A1 (ja) 2013-07-04
TW201201817A (en) 2012-01-16
EP2551346A1 (en) 2013-01-30
WO2011118682A1 (ja) 2011-09-29

Similar Documents

Publication Publication Date Title
SG159458A1 (en) Novel immunoglobulin-binding proteins with improved specificity
NZ607969A (en) Cd33 binding agents
ZA201206637B (en) Conjugation process of bacterial polysaccharides to carrier proteins
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
NZ626302A (en) Bispecific binding molecules for anti-angiogenesis therapy
MX2011011531A (es) Acidos nucleicos que se unen a hepcidina.
PH12017501139A1 (en) Novel modulators and methods of use
IN2014DN03463A (pl)
MY163004A (en) Modulation of signal transducer and activator of transcription 3 (stat3) expression
MX349630B (es) Alfa-amilasas.
MX2013001472A (es) Anticuerpos biespecificos activables
MX341578B (es) Tratamiento de la osteoartritis y del dolor.
WO2011047146A3 (en) Methods of affinity maturing antibodies
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
MX2011012757A (es) Produccion biocatalitica de ambroxan.
IN2012DN00851A (pl)
EP2519491A4 (en) PURIFICATION OF BERNSTEINIC ACID FROM THE FERMENTATION OF SPROUTS WITH AMMONIUM UCCINATE
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
MY163339A (en) A method of producing ingenol-3-angelate
MX340683B (es) Anticuerpos anti-vla-4.
MX2014008454A (es) Acidos nucleicos de enlace c5a nuevos.
EP2319930A4 (en) GENES, PROTEINS AND VECTORS FOR INCREASING THE TOLERANCE OF PLANTS AND MICROBES AGAINST ABIOTIC STRESSES AND USES THEREOF
MX2011012623A (es) Construcciones de casb7439.
MX2014013754A (es) Metodos de cristalizacion para la purificacion de anticuerpos monoclonales.
GEP20156234B (en) Agomelatine intermediates and preparation method thereof